Sign up to save your podcasts
Or
Share 332: Pfizer's new R&D head, a VC deep-dive, and a new FDA commissioner?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
332: Pfizer's new R&D head, a VC deep-dive, and a new FDA commissioner?
Atlas Venture Partner Bruce Booth joins the podcast to discuss his annual year in review report, the influence of China, and what the new Trump administration might mean for innovation. Adam and Allison also recap the latest news in the life sciences, including a new science chief at Pfizer, a new job for Ned Sharpless, and the ongoing presidential appointments.
View all episodes
By STAT
4.6
300300 ratings
Atlas Venture Partner Bruce Booth joins the podcast to discuss his annual year in review report, the influence of China, and what the new Trump administration might mean for innovation. Adam and Allison also recap the latest news in the life sciences, including a new science chief at Pfizer, a new job for Ned Sharpless, and the ongoing presidential appointments.
More shows like The Readout Loud
View all
WSJ Tech News Briefing
1,642 Listeners
WSJ What’s News
4,315 Listeners
The Daily
111,521 Listeners
KFF Health News' 'What the Health?'
468 Listeners
The Long Run with Luke Timmerman
117 Listeners
The Journal.
5,892 Listeners
Morning Brew Daily
2,929 Listeners
Tradeoffs
391 Listeners
Biotech 2050 Podcast
60 Listeners
Business Of Biotech
84 Listeners
BioCentury This Week
31 Listeners
Raising Health
141 Listeners
Biotech Hangout
9 Listeners
ACQ2 by Acquired
191 Listeners
Ground Truths
42 Listeners